Viracta Therapeutics Inc VIRX
Set alert
0.01 USD 0.00 0.00%
At close · Jul 2
0.07 +0.06 +625.97%
After hours · Jul 2, 4:00 PM ET
0.00978 Day range 0.00978
0.01 52-week range 0.82
- YTD
- -93.92%
- 1 year
- -93.89%
- Open
- 0.00978
- Prev close
- 0.00978
- Mkt cap
- 388.70K
- Vol
- 0
- Avg vol
- 305.91K
- EPS
- -1.10
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.00978
- High
- 0.00978
- Forward P/E
- -0.38
- Beta
- 0.30
- Short ratio
- 1.85
- Inst. own
- 50.06%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.1908
- 200-d avg
- 0.49815
- 1y target
- 3.00
Analyst view
Consensus: none
Price target (mean) 3.00
Ratings (0m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.195 | -0.26 – -0.13 | -0.35 | +44.3% | 0 | 0.0% | 2 |
| Next quarter | 0.00 | 0.00 – 0.00 | -0.23 | 0.0% | 0 | 0.0% | 0 |
| Current year | -0.90 | -1.00 – -0.80 | -1.32 | +31.8% | 0 | 0.0% | 2 |
| Next year | -0.385 | -0.41 – -0.36 | -0.90 | +57.2% | 3.50M | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 14, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 16, 2024 | Leerink Partners | Downgrade | Outperform | Market Perform |
| Aug 15, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| May 23, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 17, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 12, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 5, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 10, 2023 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 5, 2023 | RBC Capital | Reiterated | Outperform | Outperform |
| Aug 15, 2023 | RBC Capital | Reiterated | Outperform | Outperform |
| Aug 15, 2023 | SVB Securities | Maintained | Outperform | Outperform |
| Aug 15, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 31, 2023 | EF Hutton | Initiated | — | Buy |
| Jul 5, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 10, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 9, 2023 | RBC Capital | Maintained | — | Outperform |
| May 8, 2023 | SVB Securities | Maintained | Outperform | Outperform |
| Mar 27, 2023 | Oppenheimer | Maintained | — | Outperform |
| Mar 14, 2023 | RBC Capital | Reiterated | — | Outperform |
| Mar 14, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Nov 11, 2022 | RBC Capital | Maintained | — | Outperform |
| Nov 10, 2022 | SVB Securities | Maintained | Outperform | Outperform |
| May 3, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Apr 26, 2021 | SVB Leerink | Initiated | — | Outperform |
| Mar 25, 2021 | Evercore ISI Group | Initiated | — | Outperform |